Relationship between postmenopausal hormone replacement therapy and ovarian cancer.

Relationship between postmenopausal hormone replacement therapy and ovarian cancer.

Toon andere (1) versies

Bibliografische gegevens
Hoofdauteurs:	Bosetti, C, Negri, E, Franceschi, S, Trichopoulos, D, Beral, V, La Vecchia, C
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2001

Gelijkaardige items

Relationship between postmenopausal hormone replacement therapy and ovarian cancer
door: Bosetti, C, et al.
Gepubliceerd in: (2001)

Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studies.
door: Negri, E, et al.
Gepubliceerd in: (1999)

Long-term effects of oral contraceptives on ovarian cancer risk.
door: Bosetti, C, et al.
Gepubliceerd in: (2002)

Hormone replacement therapy and ovarian cancer.
door: Beral, V, et al.
Gepubliceerd in: (1991)

HORMONE REPLACEMENT THERAPY AND OVARIAN-CANCER
door: Beral, V, et al.
Gepubliceerd in: (1991)

False alarm: postmenopausal hormone therapy and ovarian cancer - Response
door: Beral, V, et al.
Gepubliceerd in: (2007)

Ovarian cancer and hormone replacement therapy - Reply
door: Beral, V, et al.
Gepubliceerd in: (2007)

Pooled analysis of 3 European case-control studies of ovarian cancer: II. Age at menarche and at menopause.
door: Franceschi, S, et al.
Gepubliceerd in: (1991)

Pooled analysis of 3 European case-control studies of epithelial ovarian cancer: III. Oral contraceptive use.
door: Franceschi, S, et al.
Gepubliceerd in: (1991)

Ovarian cancer and hormone replacement therapy in the Million Women Study.
door: Beral, V, et al.
Gepubliceerd in: (2007)

Hormone replacement therapy increase breast cancer incidence and may increase breast cancer mortality in postmenopausal women
door: Beral, V, et al.
Gepubliceerd in: (2004)

Pooled analysis of 3 European case-control studies: I. Reproductive factors and risk of epithelial ovarian cancer.
door: Negri, E, et al.
Gepubliceerd in: (1991)

Antioxidant effects of hormone replacement therapy in postmenopausal women
door: T Delibasi, et al.
Gepubliceerd in: (2006-08-01)

Current evidence about the effect of hormone replacement therapy on the incidence of major conditions in postmenopausal women.
door: Beral, V, et al.
Gepubliceerd in: (2005)

Impact of hormone replacement therapy on breast cancer
door: Gathani, T, et al.
Gepubliceerd in: (2010)

POSTMENOPAUSAL HORMONE REPLACEMENT THERAPY; CHANGES OF THE MAMMOGRAPHIC FINDINGS
door: Ayşegül Sarsılmaz, et al.
Gepubliceerd in: (2009-01-01)

Hormone replacement therapy in postmenopause - where we stand?
door: Damir Franić
Gepubliceerd in: (2007-02-01)

Hormone replacement therapy in prevention and treatment of postmenopausal osteoporosis
door: Rajesh Hishikar, et al.
Gepubliceerd in: (2014-01-01)

Breast cancer and hormone-replacement therapy in the Million Women Study.
door: Beral, V
Gepubliceerd in: (2003)

Hormone replacement therapy
door: Grant, C, et al.
Gepubliceerd in: (1999)

HORMONE REPLACEMENT THERAPY IN POSTMENOPAUSE AND CARDIOVASCULAR DISEASES: FACTS AND DILEMMAS
door: Branka Žegura, et al.
Gepubliceerd in: (2018-02-01)

Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study.
door: Liu, B, et al.
Gepubliceerd in: (2008)

The Relationship Between Hormone Therapy and Vaginal Candidiasis in Postmenopausal Patients
door: Hüseyin Özyurt, et al.
Gepubliceerd in: (2008-08-01)

Hormone replacement therapy and high incidence of breast cancer between mammographic screens.
door: Beral, V, et al.
Gepubliceerd in: (1997)

Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study
door: Liu, B, et al.
Gepubliceerd in: (2008)

Endometrial cancer and hormone-replacement therapy in the Million Women Study.
door: Beral, V, et al.
Gepubliceerd in: (2005)

Protective effect of postmenopausal hormone replacement against urolithiasis
door: C. Tsai, et al.
Gepubliceerd in: (2020-07-01)

Hormone replacement therapy effectiveness and safety in postmenopausal women with metabolic syndrome
door: O. N. Poryvkina, et al.
Gepubliceerd in: (2009-02-01)

Modification of blood pressure in postmenopausal women: role of hormone replacement therapy
door: Cannoletta M, et al.
Gepubliceerd in: (2014-08-01)

Can hormonal replacement therapy be a solution for postmenopausal women with nocturia?
door: K. Pauwaert, et al.
Gepubliceerd in: (2020-07-01)

Predicting the effectiveness of hormone replacement therapy in postmenopausal osteoporotic changes correction
door: I S Zakharov, et al.
Gepubliceerd in: (2015-08-01)

Hormone replacement therapy for postmenopausal atherosclerosis is offset by late age iron deposition
door: Tianze Xu, et al.
Gepubliceerd in: (2023-08-01)

Effects of hormone replacement therapy and tibolone on skin thickness and bone in postmenopausal women
door: Demir Berfu, et al.
Gepubliceerd in: (2006-01-01)

Tobacco smoking, smoking cessation, and cumulative risk of upper aerodigestive tract cancers.
door: Bosetti, C, et al.
Gepubliceerd in: (2008)

Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women.
door: Banks, E, et al.
Gepubliceerd in: (2004)

Breast cancer and hormone-replacement therapy: the Million Women Study - Reply
door: Beral, V, et al.
Gepubliceerd in: (2003)

Menopausal Hormone Replacement Therapy and the Risk of Ovarian Cancer: A Meta-Analysis
door: Yang Liu, et al.
Gepubliceerd in: (2019-12-01)

Long-term effects of hormone replacement therapy - Reply
door: Beral, V, et al.
Gepubliceerd in: (2003)

Hormone replacement therapy for secondary prevention of coronary heart disease.
door: Banks, E, et al.
Gepubliceerd in: (1999)

Hormone replacement therapy for secondary prevention of coronary heart disease
door: Banks, E, et al.
Gepubliceerd in: (1999)